Global POCT Kits and Devices Market Growth (Status and Outlook) 2025-2031

The global POCT Kits and Devices market size is predicted to grow from US$ 22140 million in 2025 to US$ 34250 million in 2031; it is expected to grow at a CAGR of 7.5% from 2025 to 2031.

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

The POCT (Point of Care Testing) Kits and Devices Market are driven by the increasing demand for rapid and decentralized diagnostic solutions, offering timely and convenient healthcare testing. These kits and devices enable healthcare professionals to perform tests near the patient, reducing turnaround times and improving patient care. However, a significant challenge in this market is the need for accuracy and reliability in POCT results. Manufacturers must ensure that their products meet stringent quality standards to maintain trust in these point-of-care diagnostics. Regulatory compliance and data management also pose challenges, requiring companies to navigate complex regulatory landscapes and provide secure and efficient data handling solutions. Additionally, market competition and cost considerations necessitate a balance between affordability and advanced technology to meet the evolving demands of the healthcare industry while ensuring diagnostic accuracy.

LPI (LP Information)' newest research report, the “POCT Kits and Devices Industry Forecast” looks at past sales and reviews total world POCT Kits and Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected POCT Kits and Devices sales for 2025 through 2031. With POCT Kits and Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world POCT Kits and Devices industry.

This Insight Report provides a comprehensive analysis of the global POCT Kits and Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on POCT Kits and Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global POCT Kits and Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for POCT Kits and Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global POCT Kits and Devices.

This report presents a comprehensive overview, market shares, and growth opportunities of POCT Kits and Devices market by product type, application, key players and key regions and countries.

Segmentation by Type:
Kits
Devices

Segmentation by Application:
Hospital & Clinic
Laboratory
Household
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Abbott
LifeScan
Siemens Healthineers
Danaher
Ascensia
BioMerieux
ARKRAY
Bio-Rad Laboratories
Nova Biomedical
QuidelOrtho
Accriva
OraSure Technologies
Helena Laboratories
Phamatech
Chembio Diagnostics
Trinity Biotech
Wuhan Easy Diagnosis
Intec PRODUCT
Sinocare
Wondfo
Getein Biotech

Please note: The report will take approximately 2 business days to prepare and deliver.